Nurix Therapeutics, Inc. (NRIX) Earnings
Nurix Therapeutics, Inc. is expected to report next earnings on October 8, 2026 (in NaN days), with a consensus EPS estimate of $-0.56. NRIX has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise -8.8% over the last four).
Next earnings
Oct 8, 2026in NaN days
EPS est $-0.56 · Revenue est $24M
Track record
Beat EPS in 5 of 12 quarters
Avg surprise -8.8% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Jul 9, 2026 | $-0.73 | $-0.81 | -11.0% | $9M | -40.9% |
| Apr 8, 2026 | $-0.76 | $-0.79 | -3.9% | $6M | -58.2% |
| Jan 28, 2026 | $-0.84 | $-0.82 | +2.4% | $14M | -14.1% |
| Oct 9, 2025 | $-0.84 | $-1.03 | -22.6% | $8M | -37.1% |
| Jul 9, 2025 | $-0.71 | $-0.52 | +26.8% | $44M | +158.3% |
| Apr 8, 2025 | $-0.72 | $-0.67 | +6.9% | $18M | +18.1% |
| Jan 28, 2025 | $-0.67 | $-0.75 | -11.9% | $13M | -9.4% |
| Oct 11, 2024 | $-0.67 | $-0.67 | +0.0% | $13M | -4.0% |
| Jul 11, 2024 | $-0.66 | $-0.71 | -7.6% | $12M | -49.6% |
| Apr 10, 2024 | $-0.80 | $-0.76 | +5.0% | $17M | -6.3% |
| Feb 15, 2024 | $-0.51 | $-0.77 | -51.0% | $15M | -30.3% |
| Oct 12, 2023 | $-0.69 | $-0.68 | +1.4% | $18M | +15.2% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.